loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2010_324___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Boryung Pharmaceutical Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BORYUNG PHARMACEUTICAL CO., LTD. Seoul KR (1)

    filter

    01 Doxorubicin Hydrochloride, Synthetic (1)

    filter

    01 South Korea (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BORYUNG PHARMACEUTICAL CO., LTD. Se...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag South Korea
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Doxorubicin Hydrochloride, Synthetic

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2010-324 - Rev 01
      Valid
      Chemical
      2017-07-17
      714
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-324 - Rev 01 of Boryung Pharmaceutical Co., Ltd. Seoul Kr

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-324 - Rev 01 of Boryung Pharmaceutical Co., Ltd. Seoul Kr 1

      20

      Boryung Pharmaceutical Co., Ltd. Seoul Kr, based in South Korea, is a pharmaceutical company.

      One of their significant offerings is Doxorubicin Hydrochloride, Synthetic, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-324 - Rev 01

      This Chemical Type CEP, issued on July 17, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 714 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY